Compare BSIN & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSIN | XLO |
|---|---|---|
| Founded | 1966 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 56.9M |
| IPO Year | 1995 | 2021 |
| Metric | BSIN | XLO |
|---|---|---|
| Price | $1.43 | $9.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 509.9K | 8.9K |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.21 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $32,379,000.00 | ★ $43,766,000.00 |
| Revenue This Year | $11.55 | N/A |
| Revenue Next Year | $169.70 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 589.88 |
| 52 Week Low | $1.00 | $0.46 |
| 52 Week High | $1.67 | $25.17 |
| Indicator | BSIN | XLO |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 45.53 |
| Support Level | $1.09 | $8.52 |
| Resistance Level | $1.50 | $9.46 |
| Average True Range (ATR) | 0.06 | 0.33 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 20.58 | 16.75 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.